Modification No. P00014 to Technology Investment Agreement between Amyris, Inc. and DARPA (Living Foundries Project)
Contract Categories:
Business Finance
›
Modification Agreements
Summary
This document is an administrative modification to a Technology Investment Agreement between Amyris, Inc. and the Defense Advanced Research Projects Agency (DARPA) for the Living Foundries project, which aims to improve DNA assembly and integration systems. The modification clarifies accounting details related to a previous amendment, specifically the allocation of $80,000 to a project milestone. No substantive terms of the original agreement are changed, and all other provisions remain in effect.
EX-10.04 3 amyris201410-kex1004darpam.htm EXHIBIT 10.04 Amyris201410-KEx10.04DARPAMod14
MODIFICATION
TO
TECHNOLOGY INVESTMENT AGREEMENT
BETWEEN
AMYRIS, INC.,
5885 HOLLIS STREET
SUITE 100
EMERYVILLE, CALIFORNIA 94608
AND
THE DEFENSE ADVANCED RESEARCH PROJECTS AGENCY
675 NORTH RANDOLPH STREET
ARLINGTON, VA ###-###-####
CONCERNING
IMPROVING DNA ASSEMBLY AND INTEGRATION ACROSS PLATFORMS WITH
BETTER SYSTEMS AND TOOLS
(LIVING FOUNDRIES)
Agreement No.: HR0011-12-3-0006
Modification No.: P00014
Purchase Request No.: N/A
Total Amount of the Agreement: $8,653,604
Phase 1: $3,358,334
Phase 2 (Option): $5,295,269
Total Estimated Government Funding: $7,734,309
Phase 1: $3,022,501
Phase 2 (Option): $4,711,808
Contactor Share Contribution: $919,295
Phase 1: $335,834
Phase 2 (Option): $583,461
Funds Obligated By This Modification: $0
Total Funds Obligated To Date: $7,734,309
Authority: Article III(C)(1)
HR0011-12-3-0006 P00014 Page 2 of 2 |
The purpose of this modification is to clarify the ACRN (long line of of accounting ) referenced in Modification P00013. As such, the following administrative information (pertaining to Modification No. P00013) applies:
1. Per Modification No. P00013, Article V, “Obligation and Payment,” paragraph C, “Accounting and Appropriation Data,” is revised to reflect the inclusion of the $80,000 (PR No. HR0011412252) provided to Milestone No. 16. The Line of Accounting is shown below (as reflected in the conformed agreement provided as Enclosure 1 to Modification No. P00013):
ACRN AD: 012199 097 0400 000 N 20142015 D 1320 BLTM6 2014.MBT-02.CORE.A DARPA 255 $80,000
2. As noted above, this modification is administrative in nature and is provided only to clarify the accounting line/funding what was added to the agreement via Modification No. P00013. This modification effects no changes to the agreement – the Conformed Copy of the agreement provided as Enclosure 1 to Modification No. P00013 remains unchanged (the above noted accounting line/funding information is captured therein).
3. All terms and provisions of Agreement No. HR0011-12-3-0006 remain in full force and effect.
FOR THE DEFENSE ADVANCED RESEARCH PRODUCTS AGENCY | ||
/s/ Michael D. Blackstone 2014.11.25 | ||
(Signature & Date) | ||
Michael D. Blackstone | ||
Agreements Officer |